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Abstract
Epidemiological data suggest that between 59 and 87% of suicide victims suffered from major
depression while up to 15% of these patients will eventually commit suicide. Male gender, previous
suicide attempt(s), comorbid mental disorders, adverse life-situations, acute psycho-social
stressors etc. also constitute robust risk factors. Anxiety and minor depression present with a low
to moderate increase in suicide risk but anxiety-depression comorbidity increases this risk
dramatically Contrary to the traditional psychoanalytic approach which considers suicide as a
retrospective murder or an aggression turned in-wards, more recent studies suggest that the
motivations to commit suicide may vary and are often too obscure. Neurobiological data suggest
that low brain serotonin activity might play a key role along with the tryptophan hydroxylase gene.
Social factors include social support networks, religion etc. It is proven that most suicide victims
had asked for professional help just before committing suicide, however they were either not
diagnosed (particularly males) or the treatment they received was inappropriate or inadequate. The
conclusion is that promoting suicide prevention requires the improving of training and skills of both
psychiatrists and many non-psychiatrists and especially GPs in recognizing and treating depression
and anxiety. A shift of focus of attention is required in primary care to detect potentially suicidal
patients presenting with psychological problems. The proper use of antidepressants, after a careful
diagnostic evaluation, is important and recent studies suggest that successful acute and long-term
antidepressant pharmacotherapy reduces suicide morbidity and mortality.
Background
Understanding why aggression and destruction becomes
directed towards the self is a major challenge for psychia-
try, psychology and philosophy as well. Suicide is a com-
plex, multicausal behavioural phenomenon, and to be
able to understand the underlying factors a complex
approach is required. Although in the past decades there
have been unprecedented developments taking place in
medicine, with more possibilities to save lives than ever
before, we still need more efficient ways to tackle the
problem of suicide.
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In the past two decades there has been a substantial
decline in the suicide rates in most European countries,
and also in the US and Canada. The most pronounced
decrease took place in countries with traditionally high
suicide rates. The decline was greater in women, who
more frequently suffer from major depression and also
seek medical care more frequently than men do [1-3].
Although the causes of the declining suicide rates are not
yet fully understood, research data suggests that better rec-
ognition of major depression, as well as better availability
of treatment with antidepressants and mood stabilisers
(particularly lithium), could be one of the major underly-
ing factors [1,2,4,5].
Therefore, understanding, prediction and prevention of
suicidal behaviour is today one of the most challenging
tasks in society in general and in psychiatry in particular.
It has become a priority in particular during recent years,
as several psychological autopsy studies of suicide victims
have shown that the majority were suffering from a mood
disorder, usually major depression, with frequent comor-
bidity of various other mental disorders (in particular anx-
iety disorders [6-8]).
This line of evidence suggests that about 90% of suicide
victims suffered at least from one major (Axis I) mental
disorder, with major depression being the mental disor-
der most related to the manifestation of suicidal behav-
iour [6-11]. According to the most recent psychological
autopsy studies that have used current diagnostic classifi-
cations and sound methodology, the rate of current major
depressive episode among suicide victims from the gen-
eral population is reported to range between 59% and
87%. What is impressive is the fact that in spite of frequent
medical contact before the suicide event, only a small
minority of depressive suicide victims had received appro-
priate antidepressant pharmacotherapy, and this observa-
tion is particularly strong concerning primary care
[3,6,7,12,13]. An estimated 15% of patients with severe
major depression eventually die from suicide. In psycho-
geriatric populations it has been reported that close to
10% of patients with late-life depression die by their own
hands every year [14].
Factors underlying suicidal behaviour
The psychopathological background of suicide empha-
sises the role of several factors associated with depression.
Psychoanalytic theory emphasises aggression turned
inwards and considers suicide equal to a retrospective
murder. According to this, motivation for suicide can arise
from destructive drives (wish to kill or to be killed) as well
as a wish for reunion with someone lost. However, mod-
ern psychodynamic and cognitive theories do not con-
sider that suicide victims necessarily possess or manifest a
similar psychological or personality structure. Modern
approaches tend to focus rather on hopelessness as a core
element of suicide, resulting from continuous frustration
arising from rigidly held unrealistic expectations, where as
a consequence suicide remains the only way out [15].
Accordingly, research with elderly depressive patients
with moderate to severe depression suggests that it is more
likely for these patients to have suicidal ideation with
increasing hopelessness. However, in contrast to these
results, research on patients with milder forms of depres-
sion suggests that hopelessness seems to have little effect
on the extent of suicidal ideation [16]. Although accord-
ing to common sense, hopelessness could lead to depres-
sion, this does not seem to hold true when controlling for
the severity of depression. Patients who report moderate
or severe depression are more likely to have suicidal idea-
tion with increasing hopelessness, whereas hopelessness
per se seems to have little effect on the level of ideation at
mild or lower depression levels [16]. In other words,
hopelessness, guilt and related suicidal behaviour in MD
is a state-related, severity-dependent phenomenon, and
recurrence of suicidal ideation across depressive episodes
shows a high consistency [17-19]. To further complicate
things, there are reports correlating suicide with hopeless-
ness also in dysthymia [20], while according to one study
it is associated with alexythymia in cases of panic disorder
[21].
Suicidal ideation and thinking of death is nonetheless a
common feature of the thinking of depressives both
before and after a suicide attempt. Thoughts concerning
suicide are neither simple nor concrete and are varied in
their manifestation. Several patients fear that they will die
and do not wish to, while others desire death and are
determined to kill themselves. It is not clear whether these
states constitute consecutive phases, or represent distinct
symptoms and reflect a qualitatively different underlying
psychopathology [22]. There are different factors associ-
ated with suicide depending on gender, which may also
point to different psychological mechanisms in the back-
ground of suicide. While in the case of men low social and
family support and depersonalisation is related to suicide,
in the case of women depressive mood and anxiety is
more strongly associated [23].
Identifying biological correlates of suicide is another main
target of research. Low brain serotonergic function has
long been implicated in the background of aggression and
suicide, although low central serotonergic activity is char-
acteristic of depression as well. To date, no biological
marker has been found to distinguish explicitly between
suicidal and non-suicidal depressives, which suggests that
other clinical (such as severity of depression), personality
(such as impulsiveness) or psychosocial (acute stressors,
low social support, isolation) factors probably also play
an important role. Research indicates that low cerebrospi-Annals of General Psychiatry 2007, 6:23 http://www.annals-general-psychiatry.com/content/6/1/23
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nal fluid (CSF) 5-hydroxyindoleacetic acid (5HIAA) con-
centration might have some predictive value [24,25].
Suicide-attempting depressives have also been found to
have lower CSF homovanillic acid (HVA) levels compared
to both non-suicide attempting depressives and controls.
By contrast, controls had the same CSF HVA concentra-
tions with non-suicidal depressives and this result might
point to the involvement of dopaminergic abnormalities
in suicide but not in depression [26].
While most studies of suicide and mental disorders con-
centrate on major depression, one of the few studies deal-
ing with dysthymia suggested that platelet monoamine
oxidase (MAO) activity was significantly lower in females
but not in male dysthymic patients who had attempted
suicide [27].
Hyperactivity of the HPA axis, as reflected in abnormal
dexamethason suppression test [28] has also been impli-
cated as a risk factor for suicide in major depression,
recent large-sample prospective studies, however, suggest
that this may be true only in cases of severely ill and pre-
viously hospitalised major depressive patients pointing to
some other underlying factor [29].
Panic disorder patients with suicidal thoughts were
reported to have lower serum total cholesterol and low-
density lipoprotein levels than normal control subjects
[30]. The implications of such a finding are still unclear,
but it is well documented that low serum cholesterol lev-
els are associated with decreased central serotonin synthe-
sis [31].
The level of omega-3-fatty acids (an important contribu-
tor to central serotonin synthesis) has been found to be
inversely correlated with lifetime prevalence of unipolar
and bipolar depression [32] and also seems to be a pow-
erful predictor of future suicidal behaviour in unipolar
major depression [33]
Aggression studies have also concluded that the level of
emotional arousal is a crucial factor in expressing aggres-
sion whether towards the self or towards others. Results
indicate that unless a sufficient level of emotional alert-
ness is present, serotonergic activity cannot be linked to
aggressive behaviour [34]. This suggests that the problem
may lie in the imbalance between behavioural inhibition
mediated by the serotonergic system and the level of
arousal mediated by cathecholamines and particularly by
acethylcholine [35,36]. In other words, the patient may
express aggression either towards the self or towards the
environment when a lower threshold is present. In addi-
tion to serotonin, behavioural inhibition may be regu-
lated by noradrenalin and dopamine, which play a role in
the regulation of serotonin release [35]. Research indi-
cates that the above concerns only impulsive physical
aggression and not physical aggression in general [37-40];
however, they may also apply to suicidal behaviour
mostly in the frame of current major depression, where
impulsiveness also plays a role [22,41]. It has also been
found that history of serious impulsive aggressive behav-
iour is related to serotonergic dysregulation. It should also
be noted that arousal, mostly in the form of anxiety, is
increased in 'minor' mental disorders and comorbidity of
anxiety and depression seems to constitute an important
risk factor for suicide.
Family history of suicide in first degree relatives is a sui-
cide risk factor in cases of current major depressive
patients [6,8] and there is also evidence of familial aggre-
gation of suicide pointing to genetic factors, a finding also
confirmed by twin and adoption studies. Genetic research
has discovered a possible role of a polymorphism in the
TPH1 gene as a risk factor for suicidal behaviour, encod-
ing the enzyme catalysing the rate-limiting step of serot-
onin synthesis [42]. Some studies also implicate the role
of an insertion/deletion polymorphism of the promoter
of the serotonin transporter gene (5-HTTLPR) [43].
Because suicide is a multicausal behaviour, as well as bio-
logical and psychopathological factors, social and cultural
environment also play important roles in the determina-
tion and manifestation of suicidal behaviour. Specific
social parameters may promote or inhibit the manifesta-
tion of suicidal behaviours, as well as modify their expres-
sion [6].
Adverse life events may cause important losses in one's
life, such as physical losses from poor health condition or
burdening physical disease, sensory deficits or cognitive
decline, as well as social losses such as the death of a per-
son close to us or loss of work role or income. These
losses, when accompanied with chronic stress, may result
in social isolation that is turn worsens depression and
leads to the appearance of suicidal ideation. Social isola-
tion and poor social networks constitute a problem espe-
cially in the case of the elderly [44,45], where severe
physical disease such as renal failure or cancer represent
an additional major risk factor for a well-planned suicide
attempt [46,47]. The rate of males committing suicide is
especially high in old age, while inyounger patients being
divorced or widowed is more strongly associated with sui-
cide ideation and attempt than other social factors
[31,48]. In addition, in countries such as the US where the
multicultural composition of society allows for ethnic
comparison, a difference in the prevalence of lifetime sui-
cide attempts among different ethnicities has been
described, although causes are not clear yet. Migration,
socioeconomic status and acculturation are among the
suspected factors playing a role behind these differences,Annals of General Psychiatry 2007, 6:23 http://www.annals-general-psychiatry.com/content/6/1/23
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the role of major depression, however, is obvious even in
this case [49]. In the US, higher lifetime rates of suicide
attempt in different ethnic groups was associated with
more frequent lifetime rates of major depression [49].
There have also been gender differences described in the
case of social factors associated with suicide. Low social or
family support has been found to be associated with sui-
cide in men but not in women, while psychological fac-
tors such as depersonalisation or anxiety seem to play a
more important role in women [23].
Suicide risk factors and prediction of suicide in 
unipolar major depression
Not all patients with major depression commit suicide.
Several risk factors for suicidal behaviour have been iden-
tified and have been classified as primary (such as the
presence of psychiatric and medical conditions, severe
somatic illness, previous suicide attempts), secondary
(adverse life situations and psychosocial risk factors) and
tertiary (demographic factors such as male gender and old
age) [6,7]. However, their predictive value is far from sat-
isfactory. Suicide risk is highest when primary risk factors
are present; the presence of secondary and tertiary suicide
risk factors indicate high suicide risk almost exclusively
only in the presence of primary risk factors [6,8]. Unfortu-
nately, the association of risk factors and suicide is mainly
statistical, as they can only predict individual cases of sui-
cide to a limited extent. Awareness of risk factors, how-
ever, is a valuable tool for clinicians in estimating the
suicide risk.
Although severity is reported to be one of the strongest
correlates of suicide in patients with a depressive episode
[8,50], there is no satisfactory definition for severity of
depression. Considering only the number of symptoms
concludes that melancholia is a more severe form of
depression, and there is no difference in quality between
melancholic and non-melancholic depressives. Necessity
of hospital admission and degree of disability caused are
also possible indices of severity. Most of these considera-
tions, however, yield circular reasoning as definition of
disability includes specific symptoms such as suicidal ide-
ation, anhedonia or fatigue. Within this framework, it is
thus difficult to find specific syndromes or subtypes of
depression associated with suicidal ideation, as suicidal
ideation itself is in many cases a central component of the
definition of subtypes of depression either directly or
indirectly [51]. The clinically most important suicide risk
factors in unipolar depression [8,48] are listed in Table 1.
A risk factor only recently discovered and associated with
suicide in depressed patients is the emergence of depres-
sive mixed state (three or more simultaneously co-occur-
ring intra-depressive hypomanic symptoms in patients
with 'unipolar depression'), which overlaps with agitated
depression to a great extent. Depressive mixed state as well
as agitation substantially increases the risk of both
attempted and committed suicide [1,2,4,8,52]. They seem
to be the strongest cross-sectional predictors and the most
potent risk factors for suicide. This is very important as
many bipolar patients present with a pseudo-unipolar
clinical picture for much of their life. Risk factors for sui-
cide in the case of depressed patients include agitation,
depressive mixed states (pseudo-unipolar depression),
higher number of prior depressive episodes, comorbid
anxiety, personality disorders and alcohol dependence, as
well as sociodemographic and psycho-social factors such
as younger age, being divorced or widowed, and experi-
encing adverse life-situations that are associated with
increased suicidal ideation and higher prevalence of
attempts [2,6-8,31,52].
The high prevalence of major depression among suicide
victims also indicates that many of them had been treated
for major depression preceding or during their suicidal
event, although this is not always the case [1,6,13].
Depressed patients can seek and find professional help at
a variety of medical settings and structures. There is only
limited research data available concerning the prevalence,
method and lethality of suicide in relationship to different
healthcare settings the patients had sought help from.
Data so far indicate that most variation can be attributed
to differences in the clinical socio-demographic character-
istics of the patient population in the catchment area sup-
ported by the given healthcare setting. Differences in
available therapeutic methods might also play a role. Fur-
thermore, data indicate that a significantly higher rate of
suicidal patients communicate their intent to commit sui-
cide in a psychiatric care setting than in a general medical
care one (59% vs 19%). The same ratio is reflected in treat-
ment; in psychiatric care 60% of victims are given antide-
pressants in contrast to only 16% in general medical care
[12].
To summarise the above, in this context, prediction of sui-
cide is not impossible although it still constitutes a diffi-
Table 1: Clinically explorable suicide risk factors in unipolar 
depression
Prior suicide attempt
Current suicidal ideation, wish to die, few reasons for living
Severe symptomatology (hopelessness, guilt, insomnia, psychotic 
features)
Agitation/depressive mixed state
Comorbid substance-use, personality disorder, serious somatic illness
Permanent psycho-social stressors
Recent (acute) adverse life situations
Family history of suicide (1st and 2nd degree relatives)
Lack of family/social and medical supportAnnals of General Psychiatry 2007, 6:23 http://www.annals-general-psychiatry.com/content/6/1/23
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cult task. The statistical fact is that although depression is
very closely related to suicide, more than two thirds of
depressed patients never attempt suicide and the vast
majority of depressives never complete suicide, indicating
that other specific (suicide related) and non-specific fac-
tors besides major depression must also play a crucial
role. As some associations have been found among per-
sonal psychiatric histories, characteristics of depression at
index episode and suicidal behaviours, the clinical infor-
mation could serve as a guide for clinicians. Psychotic
patients are consistently more likely to apply violent sui-
cide methods, such as use of guns, hanging or jumping
from height [53], and thus they also have a higher risk of
completed suicide compared to non-psychotic depres-
sives [54]. In spite of theoretical considerations and
vagueness of definitions, the overall severity of symp-
tomatology as well as the presence of hopelessness can
also serve as predictors for the clinician. In a recent pro-
spective follow-up study of 269 major depressives (most
of whom were treated with antidepressants) among
patients having suicidal ideation at baseline, the decline
in suicidal ideation was predicted by preceding declines in
the levels of both depressive symptoms and hopelessness
[55]. The presence of mixed symptoms (pseudo-unipolar
depression) or agitation substantially increases the risk of
attempted and completed suicide [1,2,4,8,52].
Early identification and management of suicidal 
behaviour in unipolar major depression
Because nearly 90% of suicide attempters have major
depression, and also because a great majority of patients
attempting suicide seek professional medical help prior to
their suicidal act, early identification of suicidal behaviour
is not only possible to a significant degree, but also inter-
vention could make a difference. Recent studies with sui-
cide victims seeking medical help concerning mental
problems before committing suicide concluded that the
vast majority of them had contacted a general practitioner
(GP) concerning their problems a few months prior to
their completed suicide. However, data suggest that in the
vast majority they were prescribed 'antifatigue agents' (e.g.
vitamins) and anxiolytics instead of proper psychotropic
medication [56]. So, although early identification is pos-
sible, data indicate that recognition, management and
treatment of pre-suicidal patients is suboptimal, if not
actually poor [57]. The solution may lie in better recogni-
tion of signs of approaching suicide and awareness of
treatment possibilities. Promoting suicide prevention in
major depressive disorder thus requires improving the
training and skills of non-psychiatric healthcare profes-
sionals, especially GPs, in recognising and treating depres-
sion in medical and primary care [12,58,59].
Once the risk of suicidal behaviour is recognised, several
possibilities for prevention (treatment) arise. Lithium has
been reported to have a robust anti-suicidal effect both in
unipolar depression and bipolar disorders in a recent sys-
tematic review of 32 trials including more than 3400
patients [5]. Another comprehensive review of 34 studies
involving more than 16000 patients showed a 21-fold
risk-reduction for attempted and completed suicide in
both unipolar or in bipolar patients on long-term lithium
therapy [60]. There is, however, some concern that there
may be an over-interpretation of data on lithium as com-
pared to other agents despite its obvious superiority over
antidepressants in preventing suicide [61]. Also, the rele-
vance of lithium use to prevent recurrence of unipolar
depression has not been adequately studied.
Proper treatment of depression in itself significantly
reduces the risk for suicide, and antidepressive agents are
the only formally approved treatment for major depres-
sion [2,4,62]. There is, however, no data from controlled
trials to support an anti-suicidal effect for antidepressants,
mainly because suicidal patients are usually excluded
from randomised clinical drug trials because of ethical
considerations. However, common sense and 'uncon-
trolled' long-term, real-life clinical follow-up studies
including the most severe, frequently suicidal unipolar
major depressives suggest that antidepressants possess a
marked anti-suicidal effect when used in unipolar depres-
sive patients [54,62]. Concomitant use of benzodi-
azepines in the first few weeks of treatment significantly
speeds up the response to antidepressants at least in
patients with major depressive disorder [63].
However, despite the obvious role of antidepressants in
the background of declining suicide rates, the US Food
and Drug Administration recently issued a warning con-
cerning the use of antidepressants in children and adoles-
cents, and possibly in all age groups, because of possible
induction of suicidality (thinking and behaviour but not
completed suicide) as a result of antidepressant use by
juvenile depressives. There are a few cases where antide-
pressants do indeed raise the risk of suicide or from the
very beginning of treatment generate suicidal behaviour;
this, however, possibly happens in cases of unrecognised
pseudo-unipolar or subthreshold bipolar patients treated
as unipolar patients, and thus these suicidal behaviours
could be prevented by suitable recognition of bipolarity
within depression [2,4]. In the case of these patients (as
well as in overt bipolar patients), antidepressant mono-
therapy may induce not only rapid cycling and switching
to mania but also mixed states, characterised by agitation,
irritability, hostility and impulsivity, possibly giving rise
to suicidal ideation [2,52]. It is important to note that
there might be unrecognised pseudo-unipolar or sub-
threshold bipolar patients [2] among patients suffering
from panic disorder, social phobia or dysthymia, the
majority of whom later develop major depressive epi-Annals of General Psychiatry 2007, 6:23 http://www.annals-general-psychiatry.com/content/6/1/23
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sodes. In clinical practice it is common to diagnose these
disorders as comorbid conditions or as the sole current
diagnosis in patients suffering from bipolar disorder,
especially when it is not the classic bipolar type.
Suicide and minor depression and anxiety 
disorders
The most common psychiatric illnesses in the background
of suicide are unipolar major depression and schizophre-
nia, but other minor mental disorders, such as dysthymia
and anxiety disorders, have also been found to increase
the risk of suicide, although to a lesser extent. Studying the
effects of minor disorders on suicidal behaviour, however,
is difficult because they are often present as comorbid
conditions of major depression [64]. The importance of
minor mental disorders in suicidal behaviour was also
demonstrated by two recent studies showing that a pre-
existing anxiety disorder in combination with major
mood disorder was associated with a higher risk of suicide
attempts in comparison with major mood disorder alone
[65-67].
The World Health Organization reported that besides
schizophrenia and major mood disorders, minor mental
disorders, especially panic disorder and GAD, are also
strongly associated with functional disability [68].
Although these disorders usually manifest in a 'mild' clin-
ical picture, this does not imply that they are less incapac-
itating or burdening, nor that they do not carry a real
threat towards physical and mental capabilities. The
chronic character of these disorders, their refractory
nature and the frustration caused not only to the patient
but also to the environment often result in great distress.
In addition, if minor mental disorders go untreated or are
insufficiently treated, the most frequent long-term com-
plication is the development of major depression [69-74].
In most cases these minor mental disorders seem to be
self-restricting in the general population and in the large
number of patients treated in primary care. This, however,
poses further risks, as the biggest risk for suicide is poorly
diagnosed and treated mental disease. Research shows
that major depression is a comorbid condition with
'minor' mental disorders in most cases of suicide [6-8,75].
In general, it seems that the same factors and characteris-
tics that determine suicidal behaviour in major depressive
patients as well as treatment strategies apply for those suf-
fering from milder forms of depression and anxiety.
The current status of outcome of intervention 
concerning suicide
As mentioned earlier, proper diagnosis of major depres-
sion or minor mood and anxiety disorders of patients
seeking help for psychological problems in general prac-
tice and psychiatric care is the most important element in
prediction, recognition and treatment of possible suicidal
behaviour. It is also important to decide whether the
patient's symptoms are the result of unipolar depression
or belong to the bipolar spectrum. As antidepressive mon-
otherapy (unprotected by mood stabilisers) can increase
or induce risk of suicide in a small part of bipolar patients,
this diagnostic distinction is of prime importance After
proper diagnosis of depression, it is reasonable to accept
that depression is causally related to suicide in a great
number of suicidal victims. In this context, it can be
expected that successful treatment of depression will lead
to a lower risk for suicide [2,8,54,62].
The situation, however, is not always so simple and
straightforward. The literature suggests that approxi-
mately 75% of depressed suicide victims have a history of
previous psychiatric treatment, and 66% have had psychi-
atric treatment during the previous year. Only 50%, how-
ever, were receiving psychiatric treatment at the time of
suicide and the rate of specific and adequate antidepres-
sive pharmacotherapy is much lower still
[1,6,7,9,12,13,53,56,76]. A key element in the prevention
of suicide would be proper recognition of signs and symp-
toms of approaching suicide. Nearly 20% of suicidal
patients visit a physician the actual day they attempt sui-
cide, 40% pay a visit in the preceding week, while 66%
contact medical care within 3 months prior to a suicide
attempt. These rates are disturbing as they suggest that
most depressed suicide victims received neither proper
recognition or diagnosis, nor adequate treatment, despite
their medical contact. An astonishingly low 3% of suicidal
patients received antidepressants in adequate dosages and
only 7% percent received psychotherapy [1]. Another
study, performed during the pre-SSRI era, found that only
12% of suicide attempters with current major depression
received antidepressant pharmacotherapy in adequate
doses [13]. There are also significant gender differences in
current and previous treatment and suicide methods:
males seek and receive treatment less frequently and more
commonly use violent suicide methods [1,56,77].
Although minor mood and anxiety disorders constitute a
lower risk for suicide, their early detection and appropri-
ate treatment is an important step in suicide prevention,
as it substantially decreases the risk of subsequently devel-
oping major depression [70,72,78-81] and in this way
decreases the risk of further complications, including sui-
cide.
Conclusion
It is clear that proper and 'aggressive' treatment of major
depression aiming at achieving full remission should
always be the target, and determines to a large extent
whether suicidal behaviour is expressed or not. Any resid-
ual symptoms increase the risk of suicide and enhance theAnnals of General Psychiatry 2007, 6:23 http://www.annals-general-psychiatry.com/content/6/1/23
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burden on patients and their families as well, and lead to
the development of a chronic form of the disorder. This
chronic condition particularly predisposes patients to
demoralisation and the manifestation of suicidal behav-
iours. It is reasonable to bear in mind that we cannot pre-
vent all suicides. However, earlier recognition and more
effective acute and long-term treatment of anxiety and
depressive disorders is a key element in suicide prevention
[2,58]. The emphasis should be placed on the understand-
ing of the association of suicide with depression, and on
the detection and recognition of possible signs of suicidal
intent in patients seeking medical help, especially outside
psychiatric practice. Today, the vast majority of suicides
happen outside the domain psychiatrists see and treat,
although victims are likely to suffer from a mental disor-
der. This is a huge challenge for both medicine and soci-
ety.
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